Alkermes plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (44)

View All

Latest Posts

About This Stock More About This Stock
Alkermes Jumps 11% After Reaching Agreement With Activist Elliott
Article By: The Fly
Thursday, December 10, 2020 9:48 AM EDT
Shares of Alkermes are moving higher after the company announced a "Value Enhancement Plan" and cooperation agreement with activist Elliott Advisors.
In this article: ALKS
Read
Alkermes: Progress In Antipsychotics
Article By: MoneyShow.com
Saturday, October 17, 2020 6:16 PM EDT
Alkermes has the potential to generate solid sales based on its ability to alleviate serious mental illness while safety mitigating weight gain that is common in antipsychotics.
In this article: ALKS
Read
Alkermes Upgraded To Buy From Neutral At Mizuho
Article By: The Fly
Thursday, October 15, 2020 7:57 AM EDT
Mizuho analyst Vamil Divan upgraded Alkermes to Buy from Neutral with a price target of $24, up from $19.
In this article: ALKS
Read
Alkermes Comments On FDA Panel May Pressure Shares, Says Mizuho
Article By: The Fly
Friday, August 21, 2020 11:16 AM EDT
Analyst Vamil Divan believes details in Alkermes' announcement this morning that the FDA will hold an advisory committee meeting on October 9 to discuss ALKS 3831, a treatment of schizophrenia and bipolar disorder, may put pressure on the shares.
In this article: ALKS
Read
Alkermes Downgraded To Sell From Neutral At Goldman Sachs
Article By: The Fly
Thursday, July 30, 2020 6:05 AM EDT
Goldman Sachs analyst Terence Flynn downgraded Alkermes to Sell from Neutral with a price target of $15, down from $19.
In this article: ALKS
Read
All Posts

Latest Tweets for $ALKS

No tweets yet!